Chen, Yan <br/><br/>
Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells.  [electronic resource] 

 -  Basic & clinical pharmacology & toxicology  Dec 2007 
 - 427-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1742-7843 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-7843.2007.00142.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>CREB-Binding Protein--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Curcumin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>E1A-Associated p300 Protein--antagonists & inhibitors<br/>Gene Expression Regulation--drug effects<br/>Histone Deacetylase 1<br/>Histone Deacetylase Inhibitors<br/>Histone Deacetylases<br/>Humans<br/>I-kappa B Proteins--drug effects<br/>Inhibitory Concentration 50<br/>Leukemia--drug therapy<br/>Leupeptins--pharmacology<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--antagonists & inhibitors<br/>Receptor, Notch1--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Transcription Factor RelA--antagonists & inhibitors<br/>Tumor Necrosis Factor-alpha--metabolism